文献速递妇科

人乳头瘤病毒16/18/31/33/45型病毒载量作为宫颈上皮内瘤变及癌症预测指标与年龄的关系

Viral load of human papillomavirus types 16/18/31/33/45 as a predictor of cervical intraepithelial neoplasia and cancer by age.
PubMed 文献 · Gynecol Oncol · 2019-10-08

加拿大蒙特利尔的一项病例对照研究(2001–2010年)纳入632例HPV16/18/31/33/45阳性病例与对照,评估病毒载量对宫颈病变的独立预测价值及按年龄的诊断准确性。病毒载量随病变级别升高而升高,但诊断准确性低于其他HPV筛查分流检测,作者认为或可用于无细胞学结果(如HPV自采样)场景的分流。

要点

  • 病毒载量几何均值随病变级别升高,正常至宫颈癌为0.7至12.4拷贝/细胞。
  • 每增加1个对数单位拷贝/细胞,CIN1+与CIN2+的调整OR分别为1.3与1.2。
  • 病毒载量区分正常与CIN1+的AUC为0.70,低于其他HPV筛查分流检测的报道。

核心结论

  • HPV病毒载量的诊断准确性低于既往报道的其他HPV筛查分流检测,但在无细胞学结果(如HPV自采样)的场景中可能有助于HPV检测分流。

研究设计与样本

  • 宫颈癌风险生物标志物研究为2001至2010年加拿大蒙特利尔的病例对照研究;病例为组织学确诊的宫颈上皮内瘤变、原位腺癌或宫颈癌,对照为细胞学结果正常的常规筛查女性;分析限于632例HPV16/18/31/33/45阳性病例与对照。

主要发现

  • HPV16/18/31/33/45病毒载量几何均值在正常、CIN1、CIN2、CIN3及原位腺癌、宫颈癌中分别为0.7、3.1、4.8、7.2、12.4拷贝/细胞。
  • 每增加1个对数转换的拷贝/细胞,CIN1+与CIN2+的调整比值比分别增加1.3(95%CI 1.1-1.4)与1.2(95%CI 1.1-1.3)。
  • 该关联主要由HPV16、18、31型病毒载量驱动。
  • HPV16/18/31/33/45病毒载量区分正常与CIN1+女性的AUC在HPV阳性女性中为0.70(95%CI 0.64-0.76),30岁及以上女性为0.76(95%CI 0.66-0.86),30岁以下女性为0.66(95%CI 0.58-0.74)。

临床怎么用

  • 作者认为HPV病毒载量或可用于无细胞学结果(如HPV自采样)场景中的HPV检测分流。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We assessed whether human papillomavirus (HPV) viral load is an independent predictor of underlying cervical disease and its diagnostic accuracy by age. METHODS: The Biomarkers of Cervical Cancer Risk study was a case-control study from 2001 to 2010 in Montréal, Canada. Cases were histologically-confirmed cervical intraepithelial neoplasia (CIN), adenocarcinoma in situ (AIS), or cervical cancer cases. Controls were women presenting for routine screening with normal cytology results. We quantified HPV16/18/31/33/45 viral load from exfoliated cervical cells using a real-time PCR assay. Diagnostic accuracy of viral load was assessed using the area under the receiver operating characteristic curve (AUC). We restricted the analysis to the 632 cases and controls who were HPV16/18/31/33/45 positive. RESULTS: Geometric mean HPV16/18/31/33/45 viral load increased with severity of lesion grade, ranging from 0.7, 3.1, 4.8, 7.2, and 12.4 copies/cell in normal, CIN1, CIN2, CIN3&AIS, and cervical cancer respectively. The adjusted odds ratio of CIN1+ and CIN2+ increased respectively by 1.3 (95%CI 1.1-1.4) and 1.2 (95%CI 1.1-1.3) per log-transformed viral copy/cell increase of HPV16/18/31/33/45. This association was mainly driven by HPV16, 18, and 31 viral loads. The AUC of HPV16/18/31/33/45 viral load for discriminating between normal and CIN1+ women was 0.70 (95%CI 0.64-0.76) in HPV-positive women, and was 0.76 (95%CI 0.66-0.86) for women ≥30 years and 0.66 (95%CI 0.58-0.74) for women under 30 years. CONCLUSIONS: HPV viral load has lower diagnostic accuracy than has been reported for other HPV screening triage tests. However, it may be useful for triaging HPV tests in settings without cytology results such as HPV self-sampling.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Malagón T, Louvanto K, Ramanakumar AV, et al. Viral load of human papillomavirus types 16/18/31/33/45 as a predictor of cervical intraepithelial neoplasia and cancer by age. Gynecol Oncol. 2019. PMID: 31604665. doi:10.1016/j.ygyno.2019.09.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。